Zosano Pharma Corporation
ZSAN
ZSAN was delisted on the 10th of June, 2022.
20 hedge funds and large institutions have $19.3M invested in Zosano Pharma Corporation in 2019 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 1 reducing their positions, and 4 closing their positions.
600% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 1
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
50% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 4
5% more funds holding
Funds holding: 19 → 20 (+1)
2% less capital invested
Capital invested by funds: $19.7M → $19.3M (-$333K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
+$2.24M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.76M |
| 3 |
ACM
Aisling Capital Management
New York
|
+$1.45M |
| 4 |
TI
Telemetry Investments
New York
|
+$1.32M |
| 5 |
BlackRock
New York
|
+$186K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$1.28M |
| 2 |
MA
MYDA Advisors
Woodmere,
New York
|
-$343K |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
-$61.2K |
ZSAN Hedge Fund Activity: Q2 2019 in Review
20 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Zosano Pharma Corporation (ZSAN) for Q2 2019, worth a combined $19.3M — down 1.7% from $19.7M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new ZSAN positions and 4 closed out — a net gain of 2 holders — while 7 added to existing stakes and 1 trimmed.
The largest buyer was Alyeska Investment Group, opening a new position worth an estimated $2.24M. The largest seller was Morgan Stanley, exiting entirely with an estimated $1.28M sold.
- 20 institutional investors held Zosano Pharma Corporation (ZSAN) as of Q2 2019, up from 19 in Q1 2019.
- Funds reported $19.3M of Zosano Pharma Corporation stock for Q2 2019, down 1.7% quarter-over-quarter.
- 6 funds opened new Zosano Pharma Corporation positions in Q2 2019 and 4 closed out, a net change of +2 holders.
- The largest Zosano Pharma Corporation buyer in Q2 2019 was Alyeska Investment Group, an estimated $2.24M added.
- The largest Zosano Pharma Corporation seller in Q2 2019 was Morgan Stanley, an estimated $1.28M sold.
Based on aggregated 13F filings for Q2 2019.